Citations Database

Product/Service

Antibody or Protein Production Catalog Products Antibody Discovery Hybridoma Sequencing

Journal

Acta Pharmaceutica Sinica B Advanced Healthcare Materials Antibodies Antibody Therapeutics Biosensors Cancer Immunology Research Cancer Letters Cancer Research Communications Cancers Carbohydrate Polymers Cell Biomaterials Cell Death and Disease Cell Research Cell Systems EMBO Molecular Medicine eBioMedicine European Journal of Immunology Food and Agricultural Immunology Frontiers in Immunology iScience Immunopharmacology and Immunotoxicology Immunotherapy JCI Insight Journal for ImmunoTherapy of Cancer Journal of Autoimmunity Journal of Bone and Mineral Research Journal of Healthcare Engineering Journal of Immunological Methods Journal of Immunotherapy Journal of Virology MAbs Molecular Cancer Therapeutics Molecular Metabolism Nature Chemical Biology Nature Communications Neurotoxicity Research npj Vaccines Oncogene Research Science Advances Science China Life Sciences Science Immunology Scientific Reports Small Viruses

Self-Assembling Multi-Antigen T Cell Hybridizers for Precision Immunotherapy of Multiple Myeloma

Authors: Shannuo Li, Jiahui Li, Hasan Al Faruque, Paul Shami, Birgit Knoechel, Jens Lohr, Douglas Sborov, Jiyuan Yang, Jindřich Kopeček

PubMed ID: 40747784

Journal: Advanced Healthcare Materials

DOI: https://doi.org/10.1002/adhm.202502156

Products & Services: Monoclonal anti-BCMA antibody (Biointron)

Aug 01, 2025

Inhibition of long-lived plasma cells, a critical role for Telitacicept treatment to systemic lupus erythematosus

Authors: En Zhang, Chenggang Zhao, Fengzhu Wang, Ling Wang, Shenjun Li & Jing Jiang

Journal: Immunopharmacology and Immunotoxicology

PubMed ID: 40734465

DOI: https://doi.org/10.1080/08923973.2025.2511761

Products & Services: Belimumab analogue was purchased from Biointron

Jul 30, 2025

Cuproptosis improves CAR-T cell therapy in osteosarcoma

Authors: Zhenwen Huang, Nan Li1, Zhifei Gao, Jieli Chen, Zhanpeng Xue, Cuixi Wu, Jianmao Chen, Lihua Li, Yao Lu

Journal: Cell Biomaterials

DOI: https://doi.org/10.1016/j.celbio.2025.100148

Products & Services: aPD-L1 was purchased from Abinvivo (Shanghai BioIntron Biological, China)

Jul 22, 2025

Novel PAP-targeted CAR-T therapy enhances antitumor efficacy through CoupledCAR approach

Authors: Zhiyuan Cao, Chengfei Pu, Xianyang Jiang, Guiting Han, Xiaogang Shen, Wensheng Wang, Wei Ding, Zhipeng Huang, Xi Huang, Beibei Jia, Victor X Lu, Le Tian, Zhao Wu, Lei Xiao

Journal: Journal for ImmunoTherapy of Cancer

PubMed ID: 40449956

DOI: https://doi.org/10.1136/jitc-2024-011238

Products & Services: PAP antibody (BioIntron, B21482901) was used to measure PAP expression on the surfaces of PC3 cells.

May 31, 2025

An Engineered Intravitreal Injection Retinal-Pigment-Epithelium-Tropic Adeno-Associated Virus Vector Expressing a Bispecific Antibody Binding VEGF-A and ANG-2 Rescues Neovascular Age-Related Macular Degeneration in Animal Models and Patients

Authors: Yuan Cai, Yonghao Gu, Jie Zhang, Ying Zhu, Zhen Ma, Qin He, Yongjia Sun, Mengmeng Yuan, Xiaojun Li, Kai Zhu, Bolong Miao, Jin Zhao, Juan Liu, Min Tang, Dali Tong, Lixia Feng, Ming Ma, Guisheng Zhong, Zilong Qiu, and Tian Xue

Journal: Research

PubMed ID: 40443830

DOI: https://doi.org/10.34133/research.0717

Products & Services: Detection of anti-target protein antibodies was performed using rabbit anti-XMVA09 protein polyclonal antibody (Biointron) and XMVA09 protein (Biointron, China) as a positive control.

May 29, 2025

AZIN1-dependent polyamine synthesis accelerates tumor cell cycle progression and impairs effector T-cell function in osteosarcoma

Authors: Jiaming Yu, Chuanxia Zhang, Qinkai Zhang, Bing Lu, Guohao Lu, Chunxiao Zhang, Ru Qiu, Xinyue Wang, Changye Zou, Junjun Chu, Haizhou Li & Wei Zhao

Journal: Cell Death & Disease

PubMed ID: 40246846

DOI: https://doi.org/10.1038/s41419-025-07640-x

Products & Services: For PD-L1 blocking experiments, tumor cells were pre-treated with 10 µg/mL anti-PD-L1 antibody (Atezolizumab, #B2016, BIOINTRON)

Apr 17, 2025

Insights into the mechanisms of serplulimab: a distinctive anti-PD-1 monoclonal antibody, in combination with a TIGIT or LAG3 inhibitor in preclinical tumor immunotherapy studies

Authors: Yizhou Zhang,Ruicheng Wei,Ge Song,Xinyi Yang,Mengli Zhang,Wei Liu,Aiying Xiong,Xuehan Zhang,Qianhao Li,Wan-Jen Yang,Chencheng Han,Rui Liu,Chen Hu,Qingyu Wang,Jun Zhu & Yongqiang Shan

Journal: Mabs

PubMed ID: 39497266

DOI: https://doi.org/10.1080/19420862.2024.2419838

Products & Services: B2014, B6924

Nov 04, 2024

A pan-allelic human SIRPα-blocking antibody, ES004-B5, promotes tumor killing by enhancing macrophage phagocytosis and subsequently inducing an effective T-cell response

Authors: Xiaofeng Niu, Chunnian Wang, Haixia Jiang, Rui Gao, Yefeng Lu, Xiaoli Guo, Hongping Zhou, Xue Cui, Jun Sun, Quan Qiu, Dawei Sun, Hongtao Lu

Journal: Antibody Therapeutics

PubMed ID: 39257438

DOI: https://doi.org/10.1093/abt/tbae022

Products & Services: Two human IgG4 anti-SIRPα reference antibodies, HEFLB and hu1H9, were produced at Biointron according to patents WO 2017/178653 A2 and WO 2019/023347 Al. Anti-PD-L1 single-domain antibody KN035 was produced at Biointron according to patent CN 111116747 A (SEQ ID NO: 33). Anti-SIRPγ antibody LSB2.20 was purchased from Biolegend. Human IgG1, human IgG4, and mouse IgG1 isotype control antibodies were all purchased from Biointron as were the following recombinant proteins: mouse Fc-tagged huCD47 ECD, mouse Fc-tagged huSIRPα V1 ECD, and 6 × His tagged huSIRPα V8 ECD.

Aug 28, 2024

The spatial and single-cell analysis reveals remodeled immune microenvironment induced by synthetic oncolytic adenovirus treatment

Authors: Gan Liu, Qifan Hu, Shuguang Peng, Hui Ning, Jiajia Mai, Xi Chen, Minzhen Tao, Qiang Liu, Huiya Huang, Yun Jiang, Yanhua Ding, Xuegong Zhang, Jin Gu, Zhen Xie

Journal: Cancer Letters

PubMed ID: 38008394

DOI: https://doi.org/10.1016/j.canlet.2023.216485

Products & Services: Mouse PD-L1 antibody was bought from Biointron Biotechnology (B176401)

Jan 28, 2024

NF1 deficiency drives metabolic reprogramming in ER+ breast cancer

Authors: Rachel Rae J House, Elizabeth A Tovar, Luke N Redlon, Curt J Essenburg, Patrick S Dischinger, Abigail E Ellis, Ian Beddows, Ryan D Sheldon, Evan C Lien, Carrie R Graveel, Matthew R Steensma

Journal: Molecular Metabolism

PubMed ID: 38216123

DOI: https://doi.org/10.1016/j.molmet.2024.101876

Products & Services: iNF-07E (gifted by iNFiXion Bioscience, Biointron, Cat# B21900201, primary 1:500, secondary 1:2000

Jan 10, 2024